Patents by Inventor Marijke Holtrop

Marijke Holtrop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic immunization against cervical carcinoma
    Publication number: 20070166328
    Abstract: An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
    Type: Application
    Filed: March 7, 2007
    Publication date: July 19, 2007
    Applicant: Rijksuniversiteit Groningen
    Inventors: Djoeke Regts, Marijke Holtrop, Jan Wilschut, Catharina Daemen
  • Genetic immunization against cervical carcinoma
    Patent number: 7198792
    Abstract: An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: April 3, 2007
    Assignee: Rijksuniversiteit Groningen
    Inventors: Djoeke Geesje Regts, Marijke Holtrop, Jan Christiaan Wilschut, Catharina Arnoldine H. H. Daemen
  • Genetic immunization against cervical carcinoma
    Publication number: 20040005711
    Abstract: An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
    Type: Application
    Filed: April 4, 2003
    Publication date: January 8, 2004
    Inventors: Djoeke Geesje Regts, Marijke Holtrop, Jan Christiaan Wilschut, Catharina Arnoldine H. H. Daemen